Equillium, Inc. SEC filings EQ
Equillium, Inc. has 465 filings in SEC EDGAR's recent list, going back to Aug 3, 2018. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (unregistered share sale, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 15, 2026 | — |
| DEF 14A | Proxy statement | Apr 15, 2026 | May 28, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2026 | May 28, 2026 |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | May 21, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 28, 2025 | May 21, 2025 |
| DEFA14A | Additional proxy material | Apr 11, 2024 | — |
| DEF 14A | Proxy statement | Apr 11, 2024 | May 22, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2024 | May 22, 2024 |
| DEFA14A | Additional proxy material | Apr 13, 2023 | — |
| DEF 14A | Proxy statement | Apr 11, 2023 | May 22, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2023 | May 22, 2023 |
| DEFA14A | Additional proxy material | Apr 13, 2022 | — |
| DEF 14A | Proxy statement | Apr 13, 2022 | May 24, 2022 |
| DEFA14A | Additional proxy material | Apr 9, 2021 | — |
| DEF 14A | Proxy statement | Apr 9, 2021 | May 26, 2021 |
| DEF 14A | Proxy statement | Apr 3, 2020 | May 19, 2020 |
| DEF 14A | Proxy statement | Apr 25, 2019 | Jun 11, 2019 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EQ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1746466
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.